Shareholders update and review 2nd half 2016

Background Fulhold Pharma is a UK-registered company which produces the patented CarboHydrate Derived Fulvic Acid (CHD-FA) and formulations containing this product. CHD-FA provides a new pharmaceutical platform technology with a wide range of applications in human and animal health. CHD-FA is a broad-spectrum anti-microbial/anti-inflammatory compound active on drug resistant Gram positive, Gram negative, and fungal pathogens that can be both ingested and topically applied safely. This powerful antimicrobial activity makes CHD-FA an effective agent in the fight against infection, including drug-resistant forms, in human and animal health and oral health applications. In addition, CHD-FA in combination with lower levels of […]

Read more »

Fulhold Pharma PLC – Investor Update September 2015

The purpose of this document is to outline Fulhold Pharma’s current and planned scientific and commercial status in order to inform both current and potential investors. What is the nature and status of Fulhold Pharma’s business ? Fulhold Pharma Plc (‘Fulhold’) is a UK registered biotechnology company. Fulhold Pharma develops and commercialises the worldwide use of its patented active ingredient Carbohydrate Derived Fulvic Acid (CHD-FA) in Human and Animal Healthcare. CHD-FA is a type of Fulvic Acid that is pure, safe and manufactured to exacting reference standards. CHD-FA does not suffer from the variable quality and contamination that prevent environmental sources […]

Read more »

GXG Listing Questions and Answers

This document is additional information and should be read in conjunction with the Fulhold Pharma GXG Admission Document. This document is for informational purposes only and is intended for existing shareholders of Fulhold Pharma PLC and certain other interested parties. This document is not an invitation to invest in securities of Fulhold Pharma PLC and neither should it be construed as an inducement to do so. Fulhold Pharma Plc (‘Fulhold’) is a UK registered biotechnology company. Fulhold Pharma develops and commercialises the worldwide use of its patented active ingredient Carbohydrate Derived Fulvic Acid (CHD-FA) in Human and Animal Healthcare. CHD-FA […]

Read more »